Cargando…
Antigenicity and Immunogenicity of Plasmodium vivax Merozoite Surface Protein-3
A recent clinical trial in African children demonstrated the potential utility of merozoite surface protein (MSP)-3 as a vaccine against Plasmodium falciparum malaria. The present study evaluated the use of Plasmodium vivax MSP-3 (PvMSP-3) as a target antigen in vaccine formulations against malaria...
Autores principales: | Bitencourt, Amanda R., Vicentin, Elaine C., Jimenez, Maria C., Ricci, Ricardo, Leite, Juliana A., Costa, Fabio T., Ferreira, Luis C., Russell, Bruce, Nosten, François, Rénia, Laurent, Galinski, Mary R., Barnwell, John W., Rodrigues, Mauricio M., Soares, Irene S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573074/ https://www.ncbi.nlm.nih.gov/pubmed/23457498 http://dx.doi.org/10.1371/journal.pone.0056061 |
Ejemplares similares
-
Plasmodium vivax: who cares?
por: Galinski, Mary R, et al.
Publicado: (2008) -
Plasmodium vivax Merozoite Surface Protein-3 (PvMSP3): Expression of an 11 Member Multigene Family in Blood-Stage Parasites
por: Jiang, Jianlin, et al.
Publicado: (2013) -
A large scale Plasmodium vivax- Saimiri boliviensis trophozoite-schizont transition proteome
por: Anderson, D. C., et al.
Publicado: (2017) -
Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys
por: Burns, James M., et al.
Publicado: (2016) -
In silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9
por: Rodrigues-da-Silva, Rodrigo Nunes, et al.
Publicado: (2016)